ANI Pharmaceuticals | ANIP - Net Income


ANI Pharmaceuticals reported $29.49M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
AbbVie USD 3.61B 2.92B Jun/2026
ANI Pharmaceuticals USD 29.49M 2.86M Mar/2026
Aurora Cannabis CAD -71.1M 72.92M Mar/2026
Canopy Growth CAD -157.11M 94.49M Mar/2026
Eli Lilly USD 7.1B 301M Jun/2026
Emergent BioSolutions USD -261.3M 78.3M Jun/2023
Heron Therapeutics USD -2.95M 14.54M Dec/2025
Hikma Pharmaceutical USD 164M 45M Dec/2025
Knight Therapeutics CAD -3.79M 8.83M Sep/2025
Nektar Therapeutics USD -44.9M 8.82M Mar/2026
Novartis USD 3.16B 747M Mar/2026
Omeros USD -32.23M 23.81M Sep/2024
Perrigo USD 74.5M 473.1M Jun/2026
Sun Pharmaceuticals INR 28.95B 1.81B Jun/2026
Teva Pharmaceutical Industries USD -576M 945M Jun/2026